These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 3283563

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue.
    Perez-Leal O, Sierra AY, Barrero CA, Moncada C, Martinez P, Cortes J, Lopez Y, Salazar LM, Hoebeke J, Patarroyo MA.
    Biochem Biophys Res Commun; 2005 Jun 17; 331(4):1178-84. PubMed ID: 15883000
    [Abstract] [Full Text] [Related]

  • 24. Malaria vaccines.
    Gordon DM.
    Infect Dis Clin North Am; 1990 Jun 17; 4(2):299-313. PubMed ID: 2189001
    [Abstract] [Full Text] [Related]

  • 25. [Achievements and perspectives of research into development of a vaccine against malaria].
    Wiśniewski M, Zak DJ.
    Wiad Parazytol; 2010 Jun 17; 56(2):133-40. PubMed ID: 20707297
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.
    Gregory JA, Li F, Tomosada LM, Cox CJ, Topol AB, Vinetz JM, Mayfield S.
    PLoS One; 2012 Jun 17; 7(5):e37179. PubMed ID: 22615931
    [Abstract] [Full Text] [Related]

  • 30. A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.
    Herrington DA, Clyde DF, Murphy JR, Baqar S, Levine MM, do Rosario V, Hollingdale MR.
    Trop Geogr Med; 1988 Apr 17; 40(2):124-7. PubMed ID: 3043855
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Target antigens in malaria transmission blocking immunity.
    Carter R, Miller LH, Rener J, Kaushal DC, Kumar N, Graves PM, Grotendorst CA, Gwadz RW, French C, Wirth D.
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov 13; 307(1131):201-13. PubMed ID: 6151684
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Toward the development of effective transmission-blocking vaccines for malaria.
    Nikolaeva D, Draper SJ, Biswas S.
    Expert Rev Vaccines; 2015 May 13; 14(5):653-80. PubMed ID: 25597923
    [Abstract] [Full Text] [Related]

  • 36. Antibody Therapy Goes to Insects: Monoclonal Antibodies Can Block Plasmodium Transmission to Mosquitoes.
    Coelho CH, Jore MM, Canepa GE, Barillas-Mury C, Bousema T, Duffy PE.
    Trends Parasitol; 2020 Nov 13; 36(11):880-883. PubMed ID: 33036937
    [Abstract] [Full Text] [Related]

  • 37. Prospects for a malaria vaccine.
    Coppel RL.
    Microbiol Sci; 1986 Oct 13; 3(10):292-5. PubMed ID: 3153563
    [Abstract] [Full Text] [Related]

  • 38. mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
    Hayashi CTH, Cao Y, Clark LC, Tripathi AK, Zavala F, Dwivedi G, Knox J, Alameh MG, Lin PJC, Tam YK, Weissman D, Kumar N.
    NPJ Vaccines; 2022 Dec 01; 7(1):155. PubMed ID: 36456563
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.
    Nunes JK, Woods C, Carter T, Raphael T, Morin MJ, Diallo D, Leboulleux D, Jain S, Loucq C, Kaslow DC, Birkett AJ.
    Vaccine; 2014 Sep 29; 32(43):5531-9. PubMed ID: 25077422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.